TITLE

AGENIX SUCCESSFULLY COMPLETES PHASE IA BLOOD CLOT TRIAL

PUB. DATE
August 2003
SOURCE
Worldwide Biotech;Aug2003, Vol. 15 Issue 8, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the completion of patient-treatment component of phase Ia trial for ThromboView, a blood clot-detection technology of Agenix Limited.
ACCESSION #
10400340

 

Related Articles

  • Former Pfizer Worldwide Business Development Director Joins Australian Drug Development Company Agenix.  // Biomedical Market Newsletter;6/7/2012, Vol. 21, p1 

    The article announces that Agenix Ltd has appointed Paul Resnick as the business advisor.

  • AGENIX FIRST QUARTER REVENUE UP 55%.  // Biotech Financial Reports;Dec2001, p1 

    Reports the increased first quarter revenue of Agenix Limited in Australia. Introduction of additional products; Investment in the Thromboview program; Rise in international sales.

  • STOCK.  // Australasian Biotechnology;Feb2011, Vol. 21 Issue 1, p39 

    A chart is presented that lists the performance of biotechnology firms listed in the Australia Securities Exchange which includes Agenix Limited, Apollo Consolidated Limited, and Ascent Pharmahealth Ltd.

  • Corporate, institute and associate members of AusBiotech.  // Australasian Biotechnology;Oct2013, Vol. 23 Issue 3, p68 

    The article lists the corporate, institute and associate members of Australia's Biotechnology Organization (AusBiotech) including Agenix Ltd., Acrux Ltd., and Avatar Corp. Pty. Ltd.

  • AUSTRALIA BIOTECHNOLOGY.  // Acquisdata Industry SnapShot: Australia Biotechnology;11/5/2015, Issue 3695, preceding p1 

    The article presents an overview of the biotechnology industry of Australia for 2015 which includes firms like Acrux Ltd., Agenix Ltd., and Avexa Ltd.

  • AUSTRALIA BIOTECHNOLOGY.  // Acquisdata Industry SnapShot: Australia Biotechnology;6/26/2015, p1 

    An industry report of the biotechnology industry in Australia is presented from publisher Acquisdata Pty. Ltd., with topics including industry news, research on differences between strategic alliances and individual scientific collaborations, and leading firms in the industry including Agenix Ltd.

  • AUSTRALIA BIOTECHNOLOGY.  // Acquisdata Industry SnapShot: Australia Biotechnology;7/7/2015, preceding p1 

    An industry report of the biotechnology industry in Australia is presented from publisher Acquisdata Pty. Ltd., with topics including industry news, research on the use of phenomics and genomics in analyzing nitrogen assimilation of a fungus, and leading firms in the industry including Agenix Ltd.

  • Recombinant Clotting Factors: A Review of Current Clinical Status. Lusher, J.M. // BioDrugs;2000, Vol. 13 Issue 4, p289 

    In the short time span since the cloning of the human genes for factors VIII, IX and VII, recombinant factor (rF)VIII, rFIX and rFVIIa concentrates have been produced and standardised, have entered clinical trials, and have been licensed for clinical use in the US, Europe and elsewhere. Even...

  • Clotting problems raise risk of SWL complications. Dahm, Philipp // Urology Times;Jun2001, Vol. 29 Issue 6, p16 

    Reports on findings of a study from the University of Vienna in Austria, which showed that patients with known coagulopathy who are treated for stones have increased risk of complications despite normal clotting parameters. Link of endourologic procedures with the lowest rate of complications;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics